Nanomedicines as emerging platform for simultaneous delivery of cancer therapeutics: new developments in overcoming drug resistance and optimizing anticancer efficacy. (5th November 2018)

• Record Type: Journal Article
• Authors: Hussain, Zahid; Arooj, Mahwish; Malik, Arif; Hussain, Fahad; Safdar, Hassan; Khan, Shahzeb; Sohail, Muhammad; Pandey, Manisha; Choudhury, Hira; Ei Thu, Hnin
• Is Part Of: Artificial cells, nanomedicine, and biotechnology. Volume 46(2018)Supplement 2
• Page Start: 1015
• Page End: 1024
• Publication Date: 2018-11-05
• Subjects: Nanomedicines -- combo delivery of therapeutics -- reversing drug resistance -- target-specific delivery -- enhanced anticancer efficacy; Artificial cells -- Periodicals; Nanotechnology -- Periodicals; Blood substitutes -- Periodicals; Tissue engineering -- Periodicals; Molecules -- Periodicals; Biotechnology -- Periodicals; 615.39
• DOI: 10.1080/21691401.2018.1478420
• Languages: English
• ISSNs: 2169-1401

Abstract

Abstract: Development and formulation of an efficient and safe therapeutic regimen for cancer theranostics are dynamically challenging. The use of mono-therapeutic cancer regimen is generally restricted to optimal clinical applications, on account of drug resistance and cancer heterogeneity. Combinatorial treatments can employ multi-therapeutics for synergistic anticancer efficacy whilst reducing the potency of individual moieties and diminishing the incidence of associated adverse effects. The combo-delivery of nanotherapeutics can optimize anti-tumor efficacy while reversing the incidence of drug resistance, aiming to homogenize pharmacological profile of drugs, enhance circulatory time, permit targeted drug accumulation, achieve multi-target dynamic approach, optimize target-specific drug binding and ensure sustained drug release at the target site. Numerous nanomedicines/nanotherapeutics have been developed by having dynamic physicochemical, pharmaceutical and pharmacological implications. These innovative delivery approaches have displayed specialized treatment effects, alone or in combination with conventional anticancer approaches (photodynamic therapy, radiotherapy and gene therapy), while reversing drug resistance and potential off-target effects. The current review presents a comprehensive overview of nanocarrier aided multi-drug therapies alongside recent advancements, future prospects, and the pivotal requirements for interdisciplinary research.